CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Trends Analyst Outlook Journalist POV

45 hedge funds and large institutions have $7.15M invested in Celldex Therapeutics in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

6% less funds holding

Funds holding: 48 → 45 (-3)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

24% less capital invested

Capital invested by funds: $9.42M → $7.15M (-$2.26M)

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$220K
Puts
$57K
Net Calls
Net Calls Change

Top Buyers

1
+$91K
2
+$84K
3
+$58K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$36.2K
5
MCP
Mirador Capital Partners
California
+$27K

Top Sellers

1
-$796K
2
-$88K
3
-$56K
4
ARTA
A.R.T. Advisors
New York
-$48K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$47.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2K
27
$2K
28
$1.76K
29
$1K
30
$1K
31
$1K
32
$76
33
$40
34
$13
35
–
36
–
37
–
38
–
39
–
1
2